Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MPNST”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Early research (Phase 1)Study completedNCT00450736
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
University of Miami 3
Early research (Phase 1)Study completedNCT00004853
What this trial is testing

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Who this might be right for
Ewing's SarcomaRhabdomyosarcomaMPNST+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Ended earlyNCT02584647
What this trial is testing

PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
SarcomaMalignant Peripheral Nerve Sheath Tumors
Gulam Manji 39
Early research (Phase 1)Study completedNCT00030784
What this trial is testing

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 28
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Not applicableActive Not RecruitingNCT05677594
What this trial is testing

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Atypical Neurofibroma
Johns Hopkins University 80
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743554
What this trial is testing

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
MPNST (Malignant Peripheral Nerve Sheath Tumor)
Girish Dhall, MD 23
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Testing effectiveness (Phase 2)Study completedNCT00949325
What this trial is testing

Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma

Who this might be right for
Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Large-scale testing (Phase 3)Ended earlyNCT00427583
What this trial is testing

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors
Novartis Pharmaceuticals 11
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Testing effectiveness (Phase 2)UnknownNCT00410462
What this trial is testing

Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcomaSmall Intestine Cancer
European Organisation for Research and Treatment of Cancer - EORTC 118
Not applicableActive Not RecruitingNCT00924196
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis Type 1Malignant Peripheral Nerve Sheath TumorPlexiform Neurofibroma+2 more
National Cancer Institute (NCI) 259
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Not applicableStudy completedNCT04774289
What this trial is testing

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Peripheral Nerve Neoplasms, Malignant
National Cancer Institute (NCI) 296
Testing effectiveness (Phase 2)Looking for participantsNCT07549022
What this trial is testing

Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsMPNST
Ankit Mangla, MD 17
Next Page